Male fertility is independent of Enh13 control of Sox9 testicular expression
Development · 15.11.2026 · 153 (21)
DOI: 10.1242/dev.205718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Development, online erschienen am 09.11.2026. Verfasst von Maor Lubman und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Mina and Everard Goodman Faculty of Life Sciences and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan 5290…. Hauptthemen laut MEDLINE: SOX9 Transcription Factor, Testis, Gene Expression Regulation, Developmental, Fertility. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, HORIZON EUROPE European Research Council, European Research Council.
Abstract (Originalsprache)
Testis development requires precise temporal control of Sox9 expression, which is rapidly activated to initiate testis development and maintained to preserve Sertoli cell identity and male fertility. The distal enhancer Enh13 is essential for Sox9 upregulation as its constitutive deletion causes complete XY male-to-female sex reversal. Whether Enh13 is required across distinct developmental stages remains unexplored. We show that early gonadal deletion of Enh13 fully recapitulates XY sex reversal, demonstrating that Enh13 is strictly required to initiate the male pathway. In contrast, Sertoli cell-specific deletion of Enh13 after sex determination has no effect on Sox9 expression, testis architecture or male fertility, revealing that Enh13 is dispensable for Sox9 maintenance in differentiated testis. Chromatin accessibility identifies candidate enhancers gaining activity after sex determination, suggesting a potential regulatory handoff within the Sox9 locus. Finally, duplicating Enh13 in the endogenous mouse locus fails to recapitulate human XX sex reversal, suggesting that it may not be solely Enh13 sequence duplication that leads to this phenotype in humans. This work represents an in vivo demonstration of enhancer handoff during development, enabling temporally controlled interrogation of regulatory logic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Mina and Everard Goodman Faculty of Life Sciences and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel.
- Group 'Development and Pathology of the Gonad', Department of Genetics and Development, IGH, University of Montpellier, CNRS, 34396 Montpellier, France.
ORCID-Profile: Nitzan Gonen
Förderung
- Israel Science Foundation
- HORIZON EUROPE European Research Council
- European Research Council
- Bar-Ilan University
Zitieren
APA
Lubman, M., Ridnik, M., Stévant, I., Kimchi Djanshvili, Y., Abberbock, E., Ziv Lhermann, S., & Gonen, N. (2026). Male fertility is independent of Enh13 control of Sox9 testicular expression. Development, 153(21). https://doi.org/10.1242/dev.205718
Vancouver
Lubman M, Ridnik M, Stévant I, Kimchi Djanshvili Y, Abberbock E, Ziv Lhermann S, et al. Male fertility is independent of Enh13 control of Sox9 testicular expression. Development. 2026;153(21). doi:10.1242/dev.205718
BibTeX
@article{Lubman2026,
author = {Lubman, Maor and Ridnik, Meshi and Stévant, Isabelle and Kimchi Djanshvili, Yael and Abberbock, Elisheva and Ziv Lhermann, Shelly and Gonen, Nitzan},
title = {Male fertility is independent of Enh13 control of Sox9 testicular expression},
journal = {Development},
year = {2026},
volume = {153},
number = {21},
doi = {10.1242/dev.205718}
}
EUVIMED